Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Will a bunion fix make your shoes fit better? 3D scans aim to find out

NCT ID NCT07755488

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Aug 27, 2026 · Updated 3 times

Summary

This study looks at whether surgery to correct hallux valgus (a bunion) can reduce shoe size and change the shape of the front of the foot. Researchers will use 3D surface scanning to measure foot dimensions before surgery and again at 6 months after. The trial involves 100 adults undergoing a specific type of corrective surgery (Scarf + P1 osteotomy). The goal is to see if the surgery leads to a meaningful reduction in shoe size, which could improve how shoes fit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Surgical correction of hallux valgus via Scarf + P1 osteotomy
What this could lead to
If successful, this could show that hallux valgus surgery not only corrects the toe but also leads to a measurable reduction in shoe size, potentially improving comfort and fit.
What could go wrong
This is a small, single-center study without a comparison group, so results may not apply broadly. The expected shoe size change is small (at least 0.5 Paris points), and individual outcomes may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient informed about the study and signed written consent obtained in duplicate * Male or female participant aged 18 years or older * Symptomatic hallux valgus without lateral ray involvement, requiring surgical correction by Scarf + P1 osteotomy * Primary surgery planned for the affected foot * Ability to understand study information, complete questionnaires, and comply with follow-up visits (6 weeks and 6 months) Exclusion Criteria: * Previous bony surgery of the first ray or forefoot on the affected side (osteotomy, arthrodesis) * Surgical indication on lateral rays (claw toes, Weil osteotomy) * Severe lower-limb neurological or vascular disease altering gait or foot morphology (Charcot foot, critical limb ischemia, severe neuropathy) * Active inflammatory rheumatic disease (e.g., rheumatoid arthritis) with polyarticular foot involvement * Complex foot deformity requiring primary first metatarsophalangeal (MTP1) arthrodesis or procedure other than Scarf + P1 osteotomy * Pregnant or breastfeeding woman * Person under legal guardianship or unable to provide free and informed consent * Person deprived of liberty by judicial or administrative decision * Concurrent participation in another research study that could interfere with study endpoints

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hallux valgus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hallux Valgus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.